Bi news

Here are some recent bi-related news stories:

Biotech

1. Novavax COVID-19 vaccine shows 90% efficacy in phase 3 trial: Novavax announced that its COVID-19 vaccine candidate, NVX-CoV2373, demonstrated 90% efficacy in a phase 3 clinical trial. (Source: The New York Times)
2. Biogen's Aduhelm approved for Alzheimer's disease: The FDA approved Biogen's Aduhelm (aducanumab) for the treatment of Alzheimer's disease, making it the first new medication approved for the disease in nearly two decades. (Source: The Wall Street Journal)

Biopharma

1. Gilead Sciences acquires Immunomedics for $21 billion: Gilead Sciences announced that it would acquire Immunomedics, a biotech company developing cancer treatments, for $21 billion. (Source: Bloomberg)
2. Roche's Hemlibra approved for hemophilia A: The FDA approved Roche's Hemlibra (emicizumab) for the treatment of hemophilia A, a genetic disorder that affects blood clotting. (Source: Reuters)

Biotech funding

1. Biotech companies raise $1.4 billion in Q2 2021: According to a report by BioSpace, biotech companies raised $1.4 billion in funding during the second quarter of 2021, with 143 deals closed. (Source: BioSpace)
2. VC funding for biotech companies reaches $10 billion in 2021: According to a report by PitchBook, venture capital funding for biotech companies reached $10 billion in 2021, with 246 deals closed. (Source: PitchBook)

Biotech research

1. Scientists discover new gene therapy for sickle cell disease: Researchers at the University of California, San Francisco, announced that they had discovered a new gene therapy for sickle cell disease, a genetic disorder that affects hemoglobin production. (Source: Science Magazine)
2. Researchers develop new biodegradable implant for bone repair: Scientists at the University of California, Los Angeles, announced that they had developed a new biodegradable implant for bone repair, which could potentially replace traditional metal implants. (Source: Science Daily)

I hope you find these news stories interesting!